UPHOLDING THE HIGHEST MEDICAL STANDARDS
When choosing a cord blood bank, it is important to put the credentials of the company to the test. For StemCord, the medical expertise behind the company testify to the high standards for the banking of stem cells.
StemCord’s founders are renowned and experienced practising medical oncologists, hematologists and physicians with vast contributions in bone marrow and peripheral stem cell transplantation programmes in Singapore.
Licensed Medical Practitioners
Dr Teo Cheng Peng
Chairman / Medical Director and Co-Founder, StemCord Pte Ltd
Consultant Haematologist & Physician MBBS (Singapore)
M.Med (Internal Medicine)
Dr Teo Cheng Peng, born in 1959, was schooled in Kuala Lumpur. In recognition of his excellent academic results in the GCE ‘A’ Level Examinations and extracurricular activities, he was awarded the Public Service Commission Scholarship by the Singapore Government to study Medicine at the National University of Singapore. He graduated with Bachelors in Medicine and Surgery in 1984.
Upon completion of his internship in 1985, he decided to pursue postgraduate training in Internal Medicine and was accepted as a resident in the Department of Medicine, National University Hospital. He completed his residency and was conferred the Master of Medicine (Internal Medicine) in 1987. He remained in the Department to pursue advanced training in Haematology-Oncology. In recognition of his achievements, he was awarded another scholarship to train at Royal Marsden Hospital, the leading Cancer Centre in the United Kingdom. He was involved in the bone marrow and peripheral stem cell transplantation programme for the treatment of various malignancies.
Upon returning to Singapore, he developed the Bone Marrow and Peripheral Stem Cell Transplantation programme at the National University Hospital. He was Principal Physician-in-charge of the first patient to undergo bone marrow transplantation at the National University Hospital. He was awarded a major grant for his research efforts by the Singapore Totalisation Board. He was admitted as Fellow of the Academy of Medicine, Singapore, in 1993.
In 1995, Dr Teo was recruited as a Consultant Physician, to head the Bone Marrow and Stem Cell Transplantation programme in the Department of Medical Oncology, Singapore General Hospital. From 1995 to 1997, he led the team to transplant well over 50 patients with various malignancies, including breast cancer, lymphoma, multiple myeloma, Hodgkin’s Disease, leukaemia, sarcoma and nasopharyngeal cancer. In recognition of his research efforts, he was awarded another major grant by the National Medical Research Council.
Dr Teo is widely published in many peer-reviewed journals and participated in many international conferences. He is presently practising at the Parkway Cancer Centre and Gleneagles Hospital and is continuing to develop the Stem Cell Transplant programme there.
Dr Ang Peng Tiam
Director / Co-Founder, StemCord Pte Ltd
Senior Consultant Medical Oncologist & Physician MBBS (Singapore)
M.Med (Internal Medicine)
MRCP (United Kingdom)
FAMS (Medical Oncology)
Dr Ang Peng Tiam graduated from the National University of Singapore (NUS) with Bachelor of Medicine and Surgery in 1982. He did his residency in Internal Medicine and was conferred the Master of Medicine (Internal Medicine) in 1986. He completed his Fellowship in Medical Oncology at MD Anderson Cancer Centre, Houston, Texas and Stanford University Medical Centre in 1989.
Dr Ang was awarded Singapore President’s scholarship in 1977. He was awarded the Prof Sir Gordon Arthur Ransome Gold medal for being the top candidate in the Master of Medicine Clinical Examinations in 1986, and Singapore’s National Science Award in 1996 for his outstanding contributions in Medical Research. In recognition of his public service, the Sultan of Kedah conferred upon him a datukship in 2003. Dr Ang was founding Head of the Department of Medical Oncology at Singapore General Hospital from 1991 to 1997. He held the concurrent post of Director of the Oncology Centre and Clinical Associate Professor at the Faculty of Medicine, NUS. He is a council member of Singapore Cancer Society.
He was past President of Singapore Society of Oncology. He maintains a keen interest in research and has published and presented more than 100 papers and abstracts.
Dr Leong See Odd
Director / Co-Founder, StemCord Pte Ltd
M.Med (Internal Medicine) MRCP (UK)
FAMS FRCP (EDIN)
Dr Leong See Odd, born in 1961, was educated in Raffles Institution. He went on to study Medicine at the National University of Singapore. He graduated with Bachelors in Medicine and Surgery in 1986.
Upon the completion of his internship and National Service, he decided to pursue postgraduate training in Internal Medicine and was accepted a resident in the Department of Medicine (Internal Medicine) in 1991. In the same year, he passed the membership exams and was admitted as a Member of the Royal College of Physicians (United Kingdom).
Continuing in the Department of Medicine, National University Hospital, he pursued advanced training in Renal Medicine. In recognition of his achievements, he was awarded the HMDP fellowship to train in Guy’s Hospital, a leading Nephrology Centre in the United Kingdom.
He was admitted a Fellow of the Academy of Medicine of Singapore in 1996. Dr Leong has published widely in many peer-reviewed journals and participated in many international conferences. He is presently practising as a Consultant Nephrologist at Gleneagles Hospital, Singapore, and continues to serve as a Visiting Consultant at Tan Tock Seng Hospital. He is also the Physician-in-charge of many dialysis centres in Singapore.
Hope For The Future
During the course of their work, they saw many cancer patients who needed stem cell transplants but were frustrated that the option was not always available. Thus, they decided that cord blood banking would provide a form of biological insurance for patients with cancer. They started StemCord in 2002 with the commitment to provide an affordable, professional and reliable service to help people know more about stem cells and give them the opportunity to bank for future generations.
In addition, the founders insisted on a number of measures to maximise its potential as the cord blood may be useful for future treatment of organ failure. At StemCord, cord blood is stored in multiple cryo units. Having them in separate units allows us to use only what is needed as thawed cord blood cannot be re-frozen. In addition, it enables the storage of the cord blood in different locations for added security and peace of mind. True to its mission, StemCord aims to provide Hope for the Future.
“Sometimes the strength of the motherhood is greater than natural laws.”Barbara Kingsolver